Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quyushengxin recipe is a Traditional Chinese Medicine (TCM) herbal decoction developed by the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, affiliated with the Shanghai University of Traditional Chinese Medicine. It is specifically formulated for the treatment of ulcerative colitis (UC), adhering to the TCM therapeutic principle of "removing blood stasis and promoting tissue regeneration" (Quyu Shengxin). The recipe is primarily investigated for its ability to modulate the intestinal microbiome, which is often dysregulated in UC patients. Clinical studies, including trial ChiCTR1900023349, evaluate its efficacy in improving clinical symptoms and altering the composition of gut bacteria to favor a more anti-inflammatory environment. As a multi-component botanical product, it likely exerts therapeutic effects through synergistic anti-inflammatory and mucosal healing pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on quyushengxin recipe.